Services-Commercial Physical & Biological Research
Headquarters
Cincinnati, OH 45227
Fiscal year end
2025 (FY)
Market Data
Close
$609.97
Change
-$10.55
Change %
-1.70%
Volume
16,131
MEDP · trading date Oct 13, 2026 · previous close $620.52 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$2.53B
Net income
$451.12M
Total assets
$1.98B
Total liabilities
$1.52B
Stockholders' equity
$459.07M
Cash & equivalents
$497.05M
Operating income
$534.94M
Operating cash flow
$713.22M
Capital expenditures
$31.36M
Fiscal year 2025, via 10-K filed 2026-02-10.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
21.1%
Net margin
17.8%
Free cash flow
$681.87M
Free cash flow margin
26.9%
Liabilities / assets
76.8%
Equity / assets
23.2%
CapEx / revenue
1.2%
Operating cash flow / net income
1.58×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Cincinnati, OH 45227
5375 MEDPACE WAY
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:50 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.